Institutional shares held 75,665
0 calls
0 puts
Total value of holdings $205K
$0 calls
$0 puts
Market Cap $109M
39,995,900 Shares Out.
Institutional ownership 0.19%
# of Institutions 2


Latest Institutional Activity in TALS

Top Purchases

Q3 2023
Nantahala Capital Management, LLC Shares Held: 2.95M ($8.03M)
Q3 2023
Balyasny Asset Management LLC Shares Held: 1.47M ($3.99M)
Q3 2023
Great Point Partners LLC Shares Held: 1M ($2.72M)
Q3 2023
Affinity Asset Advisors, LLC Shares Held: 400K ($1.09M)
Q3 2023
Dimensional Fund Advisors LP Shares Held: 273K ($742K)

Top Sells

Q3 2023
Acuitas Investments, LLC Shares Held: 195K ($529K)
Q3 2023
Renaissance Technologies LLC Shares Held: 196K ($534K)
Q3 2023
Citadel Advisors LLC Shares Held: 114K ($311K)
Q3 2023
Jpmorgan Chase & CO Shares Held: 388K ($1.06M)
Q3 2023
Marquette Asset Management, LLC Shares Held: 40K ($109K)

About TALS

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.


Insider Transactions at TALS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
112K Shares
From 3 Insiders
Open market or private purchase 112K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Track Activities on TALS